Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Denver Bio is a regenerative medicine company based in Denver, Colorado, that specializes in the development and distribution of human-derived biologics. The company focuses on amniotic fluid, placental tissue, and umbilical cord-derived products designed to enhance the body's natural healing processes and reduce inflammation. Their product portfolio includes injectable amniotic fluid, dehydrated membrane grafts, and umbilical cord tissue, which are primarily utilized in orthopedics, wound care, and pain management. Denver Bio operates within the HCT/P regulatory framework, providing clinicians with minimally manipulated biological solutions for soft tissue repair and chronic injuries. The company aims to improve patient outcomes by offering high-quality, safe, and effective regenerative therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DenverBio.